Appraising SARS-CoV-2 infections after full mRNA COVID-19 vaccination in patients with systemic lupus erythematosus (SLE)()

The 2019 Coronavirus disease (COVID-19) vaccine is a major weapon in the fight against the severe acute respiratory syndrome brought about by coronavirus 2 (SARS-CoV-2). The vaccine significantly reduces the risk and severity of infection by SARS-CoV-2. Patients with systemic lupus erythematosus (SL...

Descripción completa

Detalles Bibliográficos
Autores principales: Anuforo, Anderson, Sandhu, Michael, Yu, Jianghong, Perl, Andras
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906889/
http://dx.doi.org/10.1016/j.clicom.2022.03.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906889/
http://dx.doi.org/10.1016/j.clicom.2022.03.002

Ejemplares similares